Patients with swallowing problems caused by cancer radiation treatment or other diseases now have a new hope, all thanks to a new Phase 1 Trial at UW Health....
For seven generations — as far back as she can track — someone in Michelle Francis’ family has died from a hereditary form of amyotrophic lateral sclerosis, or ALS. Using genealogy and research from family members, she has documented the names and faces of many...
Researchers at the University of Wisconsin School of Medicine and Public Health are investigating how well the updated monovalent COVID-19 vaccines work for inflammatory bowel disease patients....
The Wisconsin Alumni Research Foundation (WARF) today announced $134.1 million in total annual support to the University of Wisconsin-Madison research community. The overall amount extends across all grant categories and research programs for the academic year ending in 2024....
A UW Health breast cancer patient discusses her diagnosis, participation in a clinical trial, and the positive relationship with her doctor....
With the recent launch of the U.S. Food and Drug Administration’s (FDA’s) Rare Disease Endpoint Advancement (RDEA) Pilot Program, the clinical research enterprise gains new support for efforts aimed at efficacy endpoint (or clinical outcome) development and the timely approval of drugs and biological products that...
In recognition of National Hispanic Heritage Month The Association of Clinical Resrarch Professionals (ACRP) reached out to some cultural communications professionals to discuss the importance of clear communications between study teams and participants in clinical trials, no matter what their native languages may be....
The world has changed a lot in the 175 years since the founding of the University of Wisconsin. Some history-changing ideas that continue to reverberate around the globe got their start right here on the University of Wisconsin–Madison campus....
Experts say a wider diverse pool of patients needs to be given a chance to participate in clinical research to get rare disease drugs faster to market....
Enrollment in a Phase 1 trial of a new investigational universal influenza vaccine candidate has begun at the National Institutes of Health’s Clinical Center in Bethesda, Maryland. ...
